Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning

BACKGROUND: Currently, there are no satisfactory biomarkers available to screen for diffuse large B cell lymphoma (DLBCL) or to identify patients who do not benefit from standard anti-cancer therapies. In this study, we used serum proteomic mass spectra to identify potential serum biomarkers and bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xing, Wang, Bo, Zhang, Xiao-shi, Li, Zhi-ming, Guan, Zhong-zhen, Jiang, Wen-qi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242801/
https://www.ncbi.nlm.nih.gov/pubmed/18163913
http://dx.doi.org/10.1186/1471-2407-7-235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242801/
https://www.ncbi.nlm.nih.gov/pubmed/18163913
http://dx.doi.org/10.1186/1471-2407-7-235

Ejemplares similares